z-logo
Premium
A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier
Author(s) -
Grinda Marion,
Clarhaut Jonathan,
TranoyOpalinski Isabelle,
Renoux Brigitte,
Monvoisin Arnaud,
Cronier Laurent,
Papot Sébastien
Publication year - 2011
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201100355
Subject(s) - prodrug , action (physics) , computer science , computational biology , cytotoxic t cell , cancer , chemistry , combinatorial chemistry , cancer research , information retrieval , biochemistry , biology , genetics , physics , in vitro , quantum mechanics
Amplified action! We developed the therapeutic first targeting system that includes a chemical amplifier programmed both to release two potent anticancer drugs after a single enzymatic activation step and become cytotoxic itself once the amplification process is completed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here